Hypoxic hepatopathy: Pathophysiology and prognosis

Internal Medicine

Volumn 46, Issue 14, 2007, Pages 1063-1070

  Birrer, Richard ^a   Takuda, Yasuharu ^b   Takara, Tsuyoshi ^c  

^a St Luke's Medical Center   (United States)

^b St Luke's Life Science Institute   (Japan)

^c Okinawa Chubu Hospital   (Japan)

Author keywords

Hypoxic hepatitis; Ischemic hepatitis; Shock liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; LACTATE DEHYDROGENASE; OXYGEN; PROTHROMBIN; THROMBOPLASTIN;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; AGED; ANEMIA; ARTERIAL OXYGEN SATURATION; ARTICLE; AUTOPSY; CENTRAL VENOUS PRESSURE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FALLING; FEMALE; GENERAL HOSPITAL; GUNSHOT INJURY; HEART ARRHYTHMIA; HEART INDEX; HEART INFARCTION; HEART TAMPONADE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPERTHERMIA; HYPOTENSION; INTENSIVE CARE; INTOXICATION; ISCHEMIC HEART DISEASE; JAPAN; LIVER BLOOD FLOW; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; LUNG CAPILLARY PRESSURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDICAL RECORD REVIEW; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PROGNOSIS; PROTHROMBIN TIME; RESPIRATORY FAILURE; SEPSIS; SHOCK; SYSTEMIC VASCULAR RESISTANCE; TRAFFIC ACCIDENT; VALVULAR HEART DISEASE;

AGED; ANOXIA; CAUSALITY; COMORBIDITY; FEMALE; HEART FAILURE, CONGESTIVE; HEPATITIS; HUMANS; HYPOTENSION; INTENSIVE CARE UNITS; ISCHEMIA; JAPAN; LENGTH OF STAY; MALE; NEW JERSEY; PROGNOSIS; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; SHOCK; SURVIVAL ANALYSIS; WOUNDS AND INJURIES;

EID: 34548436622     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0059     Document Type: Article

References (42)

1. Kaymakcalan H, Dourdourekas D, Szant PB, Steigmann F. Congestive heart failure as a cause of fulminant hepatic failure. Am J Med 65: 384, 1978.
2. Gadeholt H. Centrilobular hepatic necrosis in cardiac failure. Acta Med Scand 176: 525-528, 1964.
3. Bynum TE, Boitnott JK, Maddrey WC. Ischemic hepatitis. Dig Dis Sci 24: 129-135, 1979.
4. Nouel O, Henrion J, Bernau J, DeGott C, Rueff B, Benhamou JP. Fulminant hepatic failure due to transient circulatory failure in patients with chronic heart disease. Dig Dis Sci 25: 49, 1980.
5. Ellenberg M, Osserman E. The role of shock in the production of central liver cell necrosis. Am J Med 11: 170-177, 1951.
6. Killip T, Payne AM. High serum transaminase activity in heart disease. Circulatory failure and hepatic necrosis. Circulation 21: 646-660, 1960.
7. Rawson JS, Achord JL. Shock liver. South Med J 78: 1421-1425, 1985.
8. Bang N. Serum glutamic-oxaloacetic transaminase activity as an index of centrilobular liver cell necrosis in cardiac and circulatory failure. Acta Med Scand 164: 385-389, 1959.
9. Birgens HS, Henriksen J, Matzen P, Paulsen H. The Shock liver. Acta Med Scand 204: 417, 1978.
10. Holden WD, de Palma RG, Drucker WR, McKalen A. Ultrastructural changes in hemorrhagic shock. Electron microscopic study of liver, kidney and striated muscle cells in rats. Ann Surg 162: 517, 1965.
11. Borokov SA, Volkova MI. Changes in the activity of certain enzymes in acute disorders of liver blood flow. Pathol Fiziol Eksp Ther 1: 57, 1974.
12. Arcidi IM Jr, Moore GW, Hutchins GM. Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 100 subjects at autopsy. Am J Pathol 104: 159-166, 1981.
13. Gitlin N, Serio KM. Ischemic hepatitis: widening horizons. Am J Gastroenterol 87: 831-836, 1992.
14. Henrion J, Schapira M, Heller FR. Ischemic hepatitis: the need for precise criteria. J Clin Gastroenterol 23: 305, 1996.
15. Henrion J, Descamps O, Luwaert R, Schapira M, Parfonry A, Heller F. Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow. J Hepatol 21: 696-703, 1994.
16. Henrion J, Schapira M, Luwaert R, Cohn L, Delannoy A, Heller FR. Hypoxic hepatitis: Clinical and hemodynamic study in 142 consecutive cases. Medicine 82 (6): 392-406, 2003.
17. Knaus WA, Draper EA, Wagner DP, Zimmerman J. Apache II: a severity of disease classification system. Crit Care Med 13: 818-829, 1985.
18. Jolliffe N. Liver function in congestive heart failure. J Clin Invest 8: 419, 1930.
19. Hajomanova B, Konikova Z, Musil J, Moserova J. Changes in biochemical indices in rat liver tissue after intraperitoneal application of endotoxin. Acta Chir Plast 21: 182, 1979.
20. Davidson CS, Lewis JH, Tagnon W, Burton V, Bishop T. Medical shock: Abnormal changes in patients with severe acute medical illnesses, with and without peripheral vascular failure. N Engl J Med 234: 279, 1946.
21. Gibson PR, Dudley FJ. Ischemic hepatitis: clinical features, diagnosis and prognosis. Aust N Z J Med 14: 822-825, 1984.
22. Seeto RK, Fenn B, Rockey DC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 109 (2): 109-113, 2001.
23. Fuchs S, Bogomolski-Yahalom V, Paltiel O, Ackerman Z. Ischemic hepatitis. Clinical and laboratory observation of 34 patients. J Clin Gastroentorol 26: 183-186, 1984.
24. Richman SM, Delman AJ, Grob D. Alteration of indices of liver function in congestive heart failure with particular reference to serum enzymes. Am J Med 30: 211, 1962.
25. Raute-Ereinsen N, Squarr HN, Houx P. Blood, chemical and ultrastructural changes in human liver, following different forms of shock. Verhandlungen der Deutschen Gesellschaft fur Pathologie 62: 275, 1978.
26. Cohen JA, Kaplan NM. Left-sided heart failure presenting as hepatitis. Gastroenterology 74: 583, 1978.
27. Irie H, Mori W. Fatal hepatic necrosis after shock. Acta Pathol Jpn 36: 363-374, 1986.
28. Henrion J, Colin L, Schmitz A, Schapira M, Heller FR Ischemic hepatitis in cirrhosis. Rare but lethal. J Clin Gastroenterol 16: 35-39, 1993.
29. Champeon HR, Jones RT, Trump BF, et al. A clinicopathologic study of hepatic dysfunction following shock. Surg Gyn Obst 142: 657, 1976.
30. Grimaud D, Philip F, Livrelli N, LeForge D. Etude biologique du foie de choc chez 1. homme. Ann Anesth Franc 20: 79, 1979.
31. Wallach HF, Popper H. Central necrosis of the liver. Arch Path 49: 33, 1950.
32. Lefer AM, Lalvin MJ. Comparison of the cytotoxic actions of hypoxia and endotoxin in the perfused cat liver. Circ Shock 5: 14, 1978.
33. Janson PMC, Kuhn SH, Geldenhuys JJ. Lysosomal disruption during the development of endotoxic shock in the baboon. S Afr Med J 49: 1041, 1975.
34. + transport during endotoxemia in rats. Am J Phys 247 (3) [Pt.2]: R465-474, 1984.
35. Lens K, Logan J, Cohem JA. Shock liver. Leber Magen Darm (Engl. Abstr.) 12 (5): 198-202, 1982.
36. Cameron DE, Edhag O, Lanfrance A. Hepatocellular dysfunction in early sepsis despite increased hepatic blood flow. Adv Shock Res 6: 65-74, 1981.
37. van Riel JM, Kerremans AL. Ischemic hepatitis. Ned Tijdschr Geneeskd 136 (42): 2078-2081, 1992.
38. Jacquemin E, Saliba E, Blond MH, Bertrand C, Vaillet W. Liver dysfunction and acute cardiocirculatory failure in children. Eur J Pediatr 151 (10): 731-734, 1992.
39. Kotake Y, Takeda J, Matsumoto M, Wasabe H, Iwata F. Subclinical hepatic dysfunction in laproscopic cholecystectomy and laparscopic colectomy. Br J Anaesth 87 (5): 774-777, 2001.
40. Turnage RH, Kadesky KM, Myers SI, Takala J, Wagner GR. Hepatic hypoperfusion after intestinal reperfusion. Surgery 119 (2): 151-160, 1996.
41. Jakob SM, Tenhunen JJ, Laitinen S, Clavian PA. Effects of systemic arterial hypoperusion on splanchnic hemodynamics and hepatic arterial buffer response in pigs. Am J Physiol Gastrointest Liver Physiol 280 (5): G819-827, 2004.
42. Dunn GD, Hayes P, Breen KJ, Schenker S. The liver in congestive heart failure: A review. Am J Med Sci 265: 174-189, 1973.